Timber Hill’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-26,300
Closed -$904K 2834
2014
Q4
$904K Buy
26,300
+3,000
+13% +$97.8K ﹤0.01% 1503
2014
Q3
$696K Sell
23,300
-4,000
-15% -$84.8K ﹤0.01% 1793
2014
Q2
$548K Buy
27,300
+11,100
+69% +$255K ﹤0.01% 2043
2014
Q1
$440K Sell
16,200
-44,400
-73% -$1.18M ﹤0.01% 2120
2013
Q4
$1.26M Buy
60,600
+50,600
+506% +$954K ﹤0.01% 1666
2013
Q3
$182K Sell
10,000
-21,500
-68% -$388K ﹤0.01% 3060
2013
Q2
$524K Buy
+31,500
New +$503K ﹤0.01% 2458

Other funds holding AUXL

Timber Hill's AUXL Position: Q3 2014 in Review

Timber Hill sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 13,454 shares — an estimated $285K sold.

Timber Hill first reported a position in AUXL in Q2 2013 and held it in 2 quarters. The position peaked at $945K in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Timber Hill reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Timber Hill sold 13,454 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $285K.
  • Timber Hill first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Timber Hill's AUXILIUM PHARAMCEUTICALS INC position peaked at $945K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Timber Hill's 13F filing for Q3 2014, filed 24 Nov 2014.